Treatment of osteoporosis with unfocused extracorporeal shock wave therapy: pilot study

Treatment of osteoporosis with unfocused extracorporeal shock wave therapy: pilot study - Shock wave therapy for osteoporosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON41686

Enrollment

Registered

2013-02-21

Start date

2015-05-02

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis porous bones

Interventions

Patients will recieve 3000 unfocused shock waves with an energy flux density of 0.30,3mJ/mm2 to one of both wrists.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Female patients, age 50-80 years, normal dietary intake inclusive calcium and/or milk products and willing to participate

Exclusion criteria

Exclusion criteria: Skin disease, systemic corticosteroid use, known with systemic disease that interacts with bone (eg. multiple myeloma, hyper(para)thyroidism, Paget*s disease or Cushing*s disease) or a previous wrist fracture

Design outcomes

Primary

Measure	Time frame
The objective of the present study is to examine whether a single treatment with unfocused extracorporeal shock wave therapy to the distal forearm leads to an increased bone mass.	—

Secondary

Measure	Time frame
To provide novel data which can be used to generate power analysis for clinical follow-up studies. To assess whether UESWT results in pain and/or complications.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)